Equillium Valuation
| EQ Stock | USD 0.75 0.02 2.60% |
Equillium is undervalued. Equillium shows a prevailing Real Value of $2.56 per share. The current price of the firm is $0.75. Our model computes the value of Equillium from reviewing the firm fundamentals such as Shares Outstanding of 35.43 M, current valuation of 1.23 M, and Profit Margin of (0.20) % as well as analyzing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Equillium's valuation include:
Price Book 1.1481 | Enterprise Value 1.2 M | Enterprise Value Ebitda 0.0666 | Price Sales 0.6401 | Forward PE 1.5314 |
Undervalued
Today
Please note that Equillium's price fluctuation is dangerous at this time. Calculation of the real value of Equillium is based on 3 months time horizon. Increasing Equillium's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Equillium's intrinsic value may or may not be the same as its current market price of 0.75, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.75 | Real 2.56 | Target 8.0 | Hype 0.75 | Naive 1.0 |
The intrinsic value of Equillium's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Equillium's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Equillium helps investors to forecast how Equillium stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Equillium more accurately as focusing exclusively on Equillium's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Equillium's intrinsic value based on its ongoing forecasts of Equillium's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Equillium's closest peers.
Equillium Cash |
|
Equillium Valuation Trend
Equillium's real value is important for investors to make better decisions and a more accurate overall view of Equillium's financial worth over time. Using both Equillium's enterprise value as well as its market capitalization is the best way to gauge the value of the company and is usually enough for investors to make market timing conclusions.
Equillium Total Value Analysis
Equillium is currently projected to have takeover value of 1.23 M with market capitalization of 27.28 M, debt of 824 K, and cash on hands of 57.56 M. Please note that takeover value may be misleading and is a subject to accounting mistakes. We encourage investors to methodically examine all of the Equillium fundamentals before making investment evaluation based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
1.23 M | 27.28 M | 824 K | 57.56 M |
Equillium Investor Information
About 36.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 1.15. Some equities with similar Price to Book (P/B) outperform the market in the long run. Equillium recorded a loss per share of 0.12. The entity had not issued any dividends in recent years. Equillium is not in a good financial situation at this time. It has a very high odds of going through financial crisis in January.Equillium Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Equillium has an asset utilization ratio of 71.41 percent. This connotes that the Company is making $0.71 for each dollar of assets. An increasing asset utilization means that Equillium is more efficient with each dollar of assets it utilizes for everyday operations.Equillium Ownership Allocation
Equillium holds a total of 35.43 Million outstanding shares. Equillium retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Equillium Profitability Analysis
The company generated the yearly revenue of 36.08 M. Annual Net Loss to common stockholders was (13.34 M) with gross profit of 15.76 M.About Equillium Valuation
The stock valuation mechanism determines Equillium's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Equillium based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Equillium. We calculate exposure to Equillium's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Equillium's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 36 M | 37.8 M | |
| Pretax Profit Margin | (0.35) | (0.37) | |
| Operating Profit Margin | (0.40) | (0.42) | |
| Net Loss | (0.37) | (0.39) | |
| Gross Profit Margin | 1.00 | 0.79 |
Equillium Growth Indicators
Investing in growth stocks can be very risky. If the company such as Equillium does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 34.7 M | |
| Forward Price Earnings | 1.5314 |
Equillium Current Valuation Indicators
Equillium's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Equillium's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Equillium, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Equillium's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Equillium's worth.Additional Tools for Equillium Stock Analysis
When running Equillium's price analysis, check to measure Equillium's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Equillium is operating at the current time. Most of Equillium's value examination focuses on studying past and present price action to predict the probability of Equillium's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Equillium's price. Additionally, you may evaluate how the addition of Equillium to your portfolios can decrease your overall portfolio volatility.